Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter 213Bi | Zendy

Adrianna Cytryniak | Zendy; Kinga Żelechowska-Matysiak | Zendy; Ewa Nazaruk | Zendy; Renata Bilewicz | Zendy; Rafał Walczak | Zendy; Emilia Majka | Zendy; Adam Mames | Zendy; Frank Bruchertseifer | Zendy; Alfred Morgenstern | Zendy; Aleksander Bilewicz | Zendy; Agnieszka MajkowskaPilip | Zendy

Open Access

Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter ²¹³Bi

Author(s) -

Adrianna Cytryniak,

Kinga Żelechowska-Matysiak,

Ewa Nazaruk,

Renata Bilewicz,

Rafał Walczak,

Emilia Majka,

Adam Mames,

Frank Bruchertseifer,

Alfred Morgenstern,

Aleksander Bilewicz,

Agnieszka MajkowskaPilip

Publication year - 2022

Publication title -

molecular pharmaceutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.13

H-Index - 127

eISSN - 1543-8392

pISSN - 1543-8384

DOI - 10.1021/acs.molpharmaceut.2c00182

Subject(s) - doxorubicin , hela , chemistry , in vivo , drug delivery , drug carrier , cancer cell , amphiphile , combinatorial chemistry , biophysics , ligand (biochemistry) , cytotoxicity , nanotechnology , in vitro , cancer , biochemistry , materials science , organic chemistry , chemotherapy , receptor , polymer , medicine , surgery , microbiology and biotechnology , copolymer , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research